BioConvergence pour la
Santé
Domaine d’Intérêt Majeur (DIM) de la Région Île-de-France
What is Bioconvergence?
Bioconvergence is the integration of biology with other fields like engineering, physics, and data science to create innovative solutions in healthcare, biotechnology, and beyond. It involves combining the principles and tools of these disciplines to address complex biological challenges more effectively. By merging biological systems with technological advancements, bioconvergence enables breakthroughs in areas such as precision medicine, advanced therapeutics, and biofabrication. This interdisciplinary approach accelerates the development of novel diagnostics, treatments, and sustainable biomanufacturing processes, fostering a new era of innovation that leverages the strengths of diverse scientific domains.
BioConvS at Medicen Day 2024
BioConvS will be present at Medicen Day on October 1st! Medicen Day 2024, une journée pour fédérer l’excellence scientifique et industrielle francilienne Le pôle de compétitivité Medicen Paris Region organise une nouvelle édition de son évènement éponyme, le...
SynBioTherapy
Join us to discuss the synergies between synthetic biology and biotherapies to shape the healthcare of the future!When: November 27th, 2024 Where: Auditorium of the Learning Planet Institute, 8bis rue Charles V 75004 ParisThis conference, co-organized by DIM BioConvS,...
Innovation Day 2024
Our 2024 symposium will take place on November 28th at the Conseil Régional d'Île-de-France (Saint-Ouen-sur-Seine). It will be an exciting opportunity for the entire DIM BioConvS community to come together, exchange ideas, and catalyse new collaborations in synthetic...
JNBB 2024: visit Genethon, I-Stem and ART-TG
Cécile Martinat (I-Stem), Giuseppe Ronzitti (Genethon), and Anne Galy (ART-TG) invite you to visit their labs! One of the main missions of BioConvS is to catalyze collaborations between its laboratories. In this spirit, we have organized, in collaboration with...
BioConvS at VivaTech 2024
The largest European innovation event dedicated to start-ups and tech took place last week, from May 22 to 25, at Paris Expo, Porte de Versailles. VivaTech aims to be a generalist event, highlighting new technologies in various fields, including health, spread...
Attend the Advanced Cell Therapy Manufacturing and Regulatory Course with BioConvS
We are delighted to annouce that BioConvS has initiated a partnership with the Intenational Society for Cell Therapy (ISCT) in order to offer to our members access to the ISCT network and training material! Established in 1992, the International Society for Cell &...
Feature your scientific images at the Festival Double Science
The Double Science Festival is back this year on June 8th&9th at Ground Control Paris! Double•Science is the free public engagement festival where citizens experiment and celebrate knowledge: for a two-way science. Following the success of the 1st edition, the...
BioConvS in La Revue Parlementaire
We're thrilled to announce that the DIM BioConvS has been featured on the current issue of La Revue Parlementaire! BioConvS coordinators, Amanda Silva Brun and Ariel Lindner, talk about our project and our commitment for the socio-economic development of...
Attend the SCI FI Program with BioConvS
We are more than happy to renew the partnership between DIM BioConvS, EIT Health, and Medicen Paris Region to offer registrations to DIM BioConvS members to participate in the EIT Health SCI FI program! This program aims to provide scientists with the necessary skills...
What is BioConvS?
BioConvergence for Health (BioConvS) is a Domain of Major Research and Innovation (DIM) funded by the Ile de France region. It aims to structure the communities of synthetic biology, biotherapy and bioproduction to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain. BioConvS, led by Université Paris Cité in partnership with Sorbonne and Paris-Saclay universities, Curie Institute (PSL), Micalis Institute (INRAe), Evry Genopole cluster, APHP and INSERM groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region.
Principal axes
BioConvS gathers the Île-de-France scientific community working on the following axes:
- Life sciences engineering and bioproduction
- Development of therapeutics proofs-of-principles
- New, high throughput, standardisable analythic methods
- Digital or AI tools to improve data analysis or modelling in quality control and production methods
- Guarantee an inclusive, ethical, sustainable Bioconvergence
Distributed Biofoundry
BioConvS will support a network of distributed biofounderies (with the participation of Sorbonne University, INRAe, Institut Curie, Genopole and Université Paris Cité) to make technologies for life design and engineering accessible to Île-de-France Region public and private R&D. This will include the acquisition and pooling of high-tech equipment dedicated to the molecular engineering of living systems and bioproduction to create genetic circuits, synthetic cells and bioprocesses on demand.
CollectivE Digital Intelligence Platform (DICE)
BioConvS will develop an AI-supported framework of digital resources to design, document and share BioConvS researchers’ profiles, expertise and projects in a virtual collaborative research space. This platform, open to the general public, will strengthen the capacity for exchange between DIM’s partners and society.
Consult our data protection policy
Address:
DIM BioConvS
Faculté des Sciences - Université Paris Cité
5 rue Thomas Mann 75013 Paris
